Skip to content

Progyny PGNY Other income, net (Note 6)

Other income, net (Note 6) at other companies

CVS Health logo
CVS HealthCVS
$32M+14.3%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$301K+468%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$32M+90.6%
Natera, Inc. logo
Natera, Inc.NTRA
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$328.5M+1.4%
Gross profit$83.1M+9.6%
Operating income$35.4M+46.4%
Net income$24.2M+60.9%
EPS (diluted)$0.29+70.6%

Balance sheet

See full
Cash & equivalents$131.6M+20.5%
Total debt$27.3M-5.6%
Total equity$439.3M-6.0%
Total assets$698.3M-4.4%

Cash flow

See full
Operating cash flow$45.9M-7.7%
CapEx$6.3M+123%
Free cash flow$39.6M-15.7%

Valuation

See full
Market cap$2.11B-27.1%

Profitability

See full
Gross margin24.1%+2.1pp
Operating margin7.5%+1.4pp
Net margin5.2%+0.9pp
FCF margin14.3%-1.9pp

Returns & leverage

See full
Return on equity14.9%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Progyny's other income, net (note 6)?
Progyny (PGNY) reported other income, net (note 6) of $1.5M in Q1 2026.
How has Progyny's other income, net (note 6) changed year-over-year?
Progyny's other income, net (note 6) decreased by 36.5% year-over-year, from $2.37M to $1.5M.
What is the long-term trend for Progyny's other income, net (note 6)?
Over 4 years (2021 to 2025), Progyny's other income, net (note 6) has grown at a 129.5% compound annual growth rate (CAGR), from -$366K to $10.16M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.